Treco James

Treco James is listed in filings as Director at Tonix Pharmaceuticals Holding Corp.. This profile follows SEC Form 4 activity through May 14, 2026, including purchase activity. Recent filings connect the profile to Tonix Pharmaceuticals Holding Corp. (TNXP). The current snapshot covers public activity from Feb 28, 2025 to May 14, 2026. Reported amounts are shown as $301.5K to $201.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.